BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohammadi A, Rashidi E, Amooeian VG. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Res 2018;265:25-38. [PMID: 29680514 DOI: 10.1016/j.psychres.2018.04.036] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Cabana-Domínguez J, Torrico B, Reif A, Fernàndez-Castillo N, Cormand B. Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders. Transl Psychiatry 2022;12:11. [PMID: 35013130 DOI: 10.1038/s41398-021-01771-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tanaka M, Spekker E, Szabó Á, Polyák H, Vécsei L. Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents-in celebration of 80th birthday of Professor Peter Riederer. J Neural Transm (Vienna) 2022. [PMID: 35624406 DOI: 10.1007/s00702-022-02513-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Ben Afia A, Aflouk Y, Saoud H, Zaafrane F, Gaha L, Bel Hadj Jrad B. Inteurleukin-8 gene variations and the susceptibility to schizophrenia. Psychiatry Res 2020;293:113421. [PMID: 32920525 DOI: 10.1016/j.psychres.2020.113421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Noyan H, Erdağ E, Tüzün E, Yaylım İ, Küçükhüseyin Ö, Hakan MT, Gülöksüz S, Rutten BPF, Saka MC, Atbaşoğlu C, Alptekin K, van Os J, Üçok A. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings. Schizophr Res 2021;229:27-37. [PMID: 33609988 DOI: 10.1016/j.schres.2021.01.014] [Reference Citation Analysis]
5 Rhoades R, Solomon S, Johnson C, Teng S. Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders. Front Microbiol 2022;13:845559. [PMID: 35444632 DOI: 10.3389/fmicb.2022.845559] [Reference Citation Analysis]
6 Huang G, Wang S, Yan J, Li C, Feng J, Chen Q, Zheng X, Li H, He Y, Young AJ, Li H, Li W, Li J, Wang L. Depression-/Anxiety-Like Behavior Alterations in Adult Slit2 Transgenic Mice. Front Behav Neurosci 2020;14:622257. [PMID: 33613201 DOI: 10.3389/fnbeh.2020.622257] [Reference Citation Analysis]
7 Liang X, Wang S, Liu L, Du Y, Cheng B, Wen Y, Zhao Y, Ding M, Cheng S, Ma M, Zhang L, Qi X, Li P, Guo X, Zhang F. Integrating genome-wide association study with regulatory SNP annotation information identified candidate genes and pathways for schizophrenia. Aging (Albany NY) 2019;11:3704-15. [PMID: 31175266 DOI: 10.18632/aging.102008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lidón L, Urrea L, Llorens F, Gil V, Alvarez I, Diez-Fairen M, Aguilar M, Pastor P, Zerr I, Alcolea D, Lleó A, Vidal E, Gavín R, Ferrer I, Del Rio JA. Disease-Specific Changes in Reelin Protein and mRNA in Neurodegenerative Diseases. Cells 2020;9:E1252. [PMID: 32438605 DOI: 10.3390/cells9051252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Yang H, Xiao W, Yang M, Wang Y, Zhang X. Decreased neuregulin1β1 in first episode and drug-naïve patients with schizophrenia: Negative correlation with cognitive impairment. Psychiatry Res 2021;304:114164. [PMID: 34388510 DOI: 10.1016/j.psychres.2021.114164] [Reference Citation Analysis]
10 Hidese S, Hattori K, Sasayama D, Tsumagari T, Miyakawa T, Matsumura R, Yokota Y, Ishida I, Matsuo J, Yoshida S, Ota M, Kunugi H. Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study. Front Pharmacol 2020;11:594394. [PMID: 33708113 DOI: 10.3389/fphar.2020.594394] [Reference Citation Analysis]
11 Akkouh IA, Hughes T, Steen VM, Glover JC, Andreassen OA, Djurovic S, Szabo A. Transcriptome analysis reveals disparate expression of inflammation-related miRNAs and their gene targets in iPSC-astrocytes from people with schizophrenia. Brain Behav Immun 2021;94:235-44. [PMID: 33571628 DOI: 10.1016/j.bbi.2021.01.037] [Reference Citation Analysis]
12 Hanger B, Couch A, Rajendran L, Srivastava DP, Vernon AC. Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin. Front Psychiatry 2020;11:789. [PMID: 32848951 DOI: 10.3389/fpsyt.2020.00789] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Cai L, Huang T, Su J, Zhang X, Chen W, Zhang F, He L, Chou KC. Implications of Newly Identified Brain eQTL Genes and Their Interactors in Schizophrenia. Mol Ther Nucleic Acids 2018;12:433-42. [PMID: 30195780 DOI: 10.1016/j.omtn.2018.05.026] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
14 Turkmen BA, Yazici E, Erdogan DG, Suda MA, Yazici AB. BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia. BMC Psychiatry 2021;21:562. [PMID: 34763683 DOI: 10.1186/s12888-021-03578-4] [Reference Citation Analysis]
15 Pagliaroli L, Fothi A, Nespoli E, Liko I, Veto B, Devay P, Szeri F, Hengerer B, Barta C, Aranyi T. Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes. Cells 2021;10:1442. [PMID: 34207710 DOI: 10.3390/cells10061442] [Reference Citation Analysis]
16 Patel S, Sharma D, Uniyal A, Akhilesh, Gadepalli A, Tiwari V. Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside. Metab Brain Dis 2022. [PMID: 35239143 DOI: 10.1007/s11011-022-00926-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sabaie H, Moghaddam MM, Moghaddam MM, Ahangar NK, Asadi MR, Hussen BM, Taheri M, Rezazadeh M. Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia. Sci Rep 2021;11:24413. [PMID: 34952924 DOI: 10.1038/s41598-021-03993-3] [Reference Citation Analysis]
18 Xu FL, Wang BJ, Yao J. Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis. Neuropsychiatr Dis Treat 2019;15:143-55. [PMID: 30643413 DOI: 10.2147/NDT.S190563] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
19 Nieto RR, Carrasco A, Corral S, Castillo R, Gaspar PA, Bustamante ML, Silva H. BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review. Front Psychiatry 2021;12:662407. [PMID: 34220575 DOI: 10.3389/fpsyt.2021.662407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Jeon JH, Oh TR, Park S, Huh S, Kim JH, Mai BK, Lee JH, Kim SH, Lee MJ. The Antipsychotic Drug Clozapine Suppresses the RGS4 Polyubiquitylation and Proteasomal Degradation Mediated by the Arg/N-Degron Pathway. Neurotherapeutics 2021. [PMID: 33884581 DOI: 10.1007/s13311-021-01039-0] [Reference Citation Analysis]
21 Grunina MN, Belinskaia MA, Zhuravlev AS, Nasyrova RF, Krupitsky EM, Taraskina AE, Zabotina AM. Aberrant alternative splicing of HTR2A exon II in peripheral blood lymphocytes of drug-naïve schizophrenic patients. Heliyon 2020;6:e05809. [PMID: 33409390 DOI: 10.1016/j.heliyon.2020.e05809] [Reference Citation Analysis]
22 Zhao Y, Xiao W, Chen K, Zhan Q, Ye F, Tang X, Zhang X. Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels. BMC Psychiatry 2019;19:403. [PMID: 31842818 DOI: 10.1186/s12888-019-2397-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Lozupone M, La Montagna M, D'Urso F, Daniele A, Greco A, Seripa D, Logroscino G, Bellomo A, Panza F. The Role of Biomarkers in Psychiatry. Adv Exp Med Biol 2019;1118:135-62. [PMID: 30747421 DOI: 10.1007/978-3-030-05542-4_7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
24 Li S, Chen D, Xiu M, Li J, Zhang XY. Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study. J Psychiatr Res 2021;134:39-47. [PMID: 33360223 DOI: 10.1016/j.jpsychires.2020.12.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Xiao MF, Roh SE, Zhou J, Chien CC, Lucey BP, Craig MT, Hayes LN, Coughlin JM, Leweke FM, Jia M, Xu D, Zhou W, Conover Talbot C Jr, Arnold DB, Staley M, Jiang C, Reti IM, Sawa A, Pelkey KA, McBain CJ, Savonenko A, Worley PF. A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function. Sci Adv 2021;7:eabf6935. [PMID: 34818031 DOI: 10.1126/sciadv.abf6935] [Reference Citation Analysis]
26 Huang L, Otrokocsi L, Sperlágh B. Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders. Brain Res Bull 2019;151:55-64. [PMID: 30721770 DOI: 10.1016/j.brainresbull.2019.01.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
27 Koricanac A, Tomic Lucic A, Veselinovic M, Bazic Sretenovic D, Bucic G, Azanjac A, Radmanovic O, Matovic M, Stanojevic M, Jurisic Skevin A, Simovic Markovic B, Pantic J, Arsenijevic N, Radosavljevic GD, Nikolic M, Zornic N, Nesic J, Muric N, Radmanovic B. Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia. Front Psychiatry 2022;13:925757. [DOI: 10.3389/fpsyt.2022.925757] [Reference Citation Analysis]
28 Dias ICS, de Campos-Carli SM, Vieira ELM, Mota APL, Azevedo PS, Anício VTDS, Guimarães FC, Mantovani LM, Cruz BF, Teixeira AL, Salgado JV. Adiponectin and Stnfr2 peripheral levels are associated with cardiovascular risk in patients with schizophrenia. J Psychiatr Res 2021:S0022-3956(21)00669-5. [PMID: 34785039 DOI: 10.1016/j.jpsychires.2021.11.020] [Reference Citation Analysis]
29 Seelig J, Heller RA, Haubruck P, Sun Q, Georg Klingenberg J, Hackler J, Crowell HL, Daniel V, Moghaddam A, Schomburg L, Biglari B. Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury. Front Neurosci 2021;15:680240. [PMID: 34140879 DOI: 10.3389/fnins.2021.680240] [Reference Citation Analysis]
30 Reis de Assis D, Szabo A, Requena Osete J, Puppo F, O'Connell KS, A Akkouh I, Hughes T, Frei E, A Andreassen O, Djurovic S. Using iPSC Models to Understand the Role of Estrogen in Neuron-Glia Interactions in Schizophrenia and Bipolar Disorder. Cells 2021;10:209. [PMID: 33494281 DOI: 10.3390/cells10020209] [Reference Citation Analysis]
31 Kargar M, Askari S, Khoshaman A, Mohammadi A. Differential diagnosis of schizophrenia and schizoaffective disorder from normal subjects using virtual reality. Psychiatry Research 2019;273:378-86. [DOI: 10.1016/j.psychres.2019.01.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ghamari R, Yazarlou F, Khosravizadeh Z, Moradkhani A, Abdollahi E, Alizadeh F. Serotonin transporter functional polymorphisms potentially increase risk of schizophrenia separately and as a haplotype. Sci Rep 2022;12:1336. [PMID: 35079035 DOI: 10.1038/s41598-022-05206-x] [Reference Citation Analysis]
33 Akkouh IA, Ueland T, Hansson L, Inderhaug E, Hughes T, Steen NE, Aukrust P, Andreassen OA, Szabo A, Djurovic S. Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells. Brain Behav Immun 2020;87:634-44. [PMID: 32109548 DOI: 10.1016/j.bbi.2020.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
34 Gowri Sankar S, Alwin Prem Anand A. Cytokine IP-10 and GM-CSF are prognostic biomarkers for severity in secondary dengue infection. Hum Immunol 2021;82:438-45. [PMID: 33766427 DOI: 10.1016/j.humimm.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ceci FM, Ferraguti G, Petrella C, Greco A, Ralli M, Iannitelli A, Carito V, Tirassa P, Chaldakov GN, Messina MP, Ceccanti M, Fiore M. Nerve Growth Factor in Alcohol Use Disorders. Curr Neuropharmacol 2021;19:45-60. [PMID: 32348226 DOI: 10.2174/1570159X18666200429003239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Keshri N, Nandeesha H, Rajappa M, Menon V. Matrix metalloproteinase-9 increases the risk of cognitive impairment in schizophrenia. Nord J Psychiatry 2021;75:130-4. [PMID: 32815771 DOI: 10.1080/08039488.2020.1808901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Pawełczyk T, Grancow-Grabka M, Trafalska E, Szemraj J, Żurner N, Pawełczyk A. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial. Psychopharmacology (Berl) 2019;236:2811-22. [PMID: 31098654 DOI: 10.1007/s00213-019-05258-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
38 Arciniegas Ruiz SM, Eldar-finkelman H. Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward. Front Mol Neurosci 2022;14:792364. [DOI: 10.3389/fnmol.2021.792364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]